Table 1.
Main characteristics of the 162 patients included in the programme
Mean ± SD age in years | 81.1 ± 6.2 |
Female, n (%) | 86 (53.1) |
Care objectives, n (%) | |
Post-acute convalescent care | 90 (55.6) |
Palliative care | 50 (30.9) |
Median of hospitalisations in the last year (range) | 2 (1–6) |
Pathologies | |
Median (range) per patient | 3 (2–6) |
Hypertension, n (%) | 124 (76.5) |
Moderate-severe renal disease, n (%) | 87 (53.7) |
Dyslipidaemia, n (%) | 84 (51.9) |
Dementia, n (%) | 78 (48.1) |
Congestive heart failure, n (%) | 71 (43.8) |
Comorbidity, n (%) | |
High | |
CCI ≥ 3 points | 126 (77.8) |
Very high | |
CCI ≥ 5 points | 83 (51.2) |
Age-adjusted CCI ≥ 5 points | 156 (96.3) |
Cognitive impairment, n (%) | |
Pfeiffer score ≥3 errors | 119 (73.5) |
Total dependence, n (%) | |
Barthel Index ≤20 points | 137 (84.6) |
Median hospital LOS in days (range) | 42.5 (3–160) |
In-hospital mortality, n (%) | 83 (51.2) |
Prescribed medication at admission | |
Total number, n | 1970* |
Mean±SD per patient | 12.2±3.7 |
≥10 medications, n (%) | 118 (72.8) |
≥15 medications, n (%) | 43 (26.5) |
≥20 medications, n (%) | 5 (3.1) |
CCI Charlson Comorbidity Index, LOS length of stay.
*Total number of admission long-term care hospital medications used to calculate reconciliation error, PIM, PPO and drug interaction rates.